Amgen Inc at Cantor Fitzgerald Global Healthcare Conference (Virtual) Transcript

Sep 27, 2021 / 06:00PM GMT
Alethia Rene Young - Cantor Fitzgerald & Co., Research Division - Director of Equity Research & Head of Healthcare Research

Hey, everybody. It's Alethia Young here. I cover large-cap, small, mid-cap biotech here at Cantor. Very happy to have Amgen with us this afternoon. We have Peter Griffith, who's the Executive Vice President and CFO. We have Susan Sweeney, who is SVP of Global Marketing, Access and Capabilities. We have Arvind Sood, who needs no introduction but VP of IR; and we have Omari Wise, who's the Executive Director in the IR team as well.

So we'll be doing a fireside chat for the next 30 minutes, and I'm just going to dive right on in.

Questions and Answers:

Alethia Rene Young - Cantor Fitzgerald & Co., Research Division - Director of Equity Research & Head of Healthcare Research

And so maybe this one is for Susan, perhaps. Just talk a little bit about how you collaborate with the commercial team to drive solutions that improve outcomes for patients and customers overall.

Susan Sweeney -
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot